CDx Diagnostics' mission of Empowering Physicians with Innovative Technology to Prevent Esophageal Cancer, One Patient at a Time is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods. Routine clinical use of CDx testing has already detected thousands of precancers that would otherwise have been missed in time for effective endoscopic treatment. Additionally, CDx Diagnostics is looking to apply its next-generation diagnostic platform to prevent cancers of the bile duct, stomach, and colon. CDx Diagnostics is a Galen Partners portfolio company.
View Top Employees from CDx Laboratories , Inc.| Website | http://www.cdxdiagnostics.com |
| Revenue | $23 million |
| Funding | $11 million |
| Employees | View employees |
| Address | 2 Executive Blvd, Suffern, New York 10901, US |
| Phone | (845) 369-7096 |
| Industry | Hospitals & Clinics, Healthcare |
| Competitors | Biomark Diagnostics Inc, Great Basin Scientific, Inc., Metabolomic Technologies Inc., Provista Diagnostics, Trinity Biotech |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies, SIC Code 8071 Companies |
| NAICS | NAICS Code 6215 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular CDx Laboratories , Inc. employee's phone or email?
CDx Laboratories , Inc. Questions
The CDx Laboratories , Inc. annual revenue was $23 million in 2024.
CDx Laboratories , Inc. is based in Suffern, New York.
The NAICS codes for CDx Laboratories , Inc. are [6215, 62151, 621, 62].
The SIC codes for CDx Laboratories , Inc. are [80, 807, 8071].
